Home › Companies › Biotechnology, Health Care, Life Science, Neuroscience, Pharmaceutical, Therapeutics › MitoChem Therapeutics
MitoChem Therapeutics
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.
Operating in biotechnology, health care, life science, neuroscience, pharmaceutical, therapeutics based in East Coast, Southern US, MitoChem Therapeutics was founded in 2011.
The company sits in the biotechnology, health care, life science, neuroscience, pharmaceutical, therapeutics segment, where it competes on its core product or service.
Its base of operations is East Coast, Southern US.
Its current recorded stage is Series_Unknown.
The company reports a headcount in the c_00001_00010 range.
Total disclosed funding stands at about $3.7M.
| Sector | Biotechnology, Health Care, Life Science, Neuroscience, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | East Coast, Southern US |
| Founded | 2011 |
| Employees | c_00001_00010 |
| Stage | series_unknown |
| Total funding | $3,725,000 |
Website: www.mitocheminc.com
Browse related
Sign in to view the contact information we hold for MitoChem Therapeutics.
Create a free account
Create a free account